-
Je něco špatně v tomto záznamu ?
Long-term risks after kidney donation: how do we inform potential donors? A survey from DESCARTES and EKITA transplantation working groups
G. Mjøen, U. Maggiore, N. Kessaris, D. Kimenai, B. Watschinger, C. Mariat, MS. Sever, M. Crespo, L. Peruzzi, G. Spasovski, SS. Sørensen, U. Heemann, J. Pascual, O. Viklicky, AE. Courtney, K. Hadaya, L. Wagner, I. Nistor, V. Hadjianastassiou, M....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 1996 do Před 1 rokem
Open Access Digital Library
od 1996-01-01
PubMed
33585931
DOI
10.1093/ndt/gfab035
Knihovny.cz E-zdroje
- MeSH
- ledviny MeSH
- lidé MeSH
- odběr tkání a orgánů MeSH
- průzkumy a dotazníky MeSH
- transplantace ledvin * škodlivé účinky MeSH
- žijící dárci MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Publications from the last decade have increased knowledge regarding long-term risks after kidney donation. We wanted to perform a survey to assess how transplant professionals in Europe inform potential kidney donors regarding long-term risks. The objectives of the survey were to determine how they inform donors and to what extent, and to evaluate the degree of variation. METHODS: All transplant professionals involved in the evaluation process were considered eligible, regardless of the type of profession. The survey was dispatched as a link to a web-based survey. The subjects included questions on demographics, the information policy of the respondent and the use of risk calculators, including the difference of relative and absolute risks and how the respondents themselves understood these risks. RESULTS: The main finding was a large variation in how often different long-term risks were discussed with the potential donors, i.e. from always to never. Eighty percent of respondents stated that they always discuss the risk of end-stage renal disease, while 56% of respondents stated that they always discuss the risk of preeclampsia. Twenty percent of respondents answered correctly regarding the relationship between absolute and relative risks for rare outcomes. CONCLUSIONS: The use of written information and checklists should be encouraged. This may improve standardization regarding the information provided to potential living kidney donors in Europe. There is a need for information and education among European transplant professionals regarding long-term risks after kidney donation and how to interpret and present these risks.
Antwerp University Hospital Antwerp Belgium
Belfast City Hospital Belfast UK
Centre Hospitalier Universitaire de Saint Etienne Saint Etienne France
Department of Medicine and Surgery University of Parma Parma Italy
Erasmus University Hospital Rotterdam Rotterdam The Netherlands
Geneva University Hospitals Geneva Switzerland
Guy's and St Thomas' Hospitals London UK
Helsinki University Hospital Helsinki Finland
Hospital del Mar Department of Nephrology Barcelona Spain
Institute for Clinical and Experimental Medicine Prague Czech Republic
Istanbul School of Medicine Istanbul Turkey
Medical University of Warsaw Warsaw Poland
Pediatric Nephrology Turin Italy
Radboud University Medical Center Nijmegen The Netherlands
Renal Unit Royal London Hospital Whitechapel Bart's Health NHS Trust London UK
Rigshospitalet København Denmark
Royal Infirmary of Edinburgh Edinburgh UK
Section of Nephrology Department of Transplant Medicine Oslo University Hospital Oslo Norway
Semmelweiss University Budapest Hungary
Technische Universität München München Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003890
- 003
- CZ-PrNML
- 005
- 20220127145744.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/ndt/gfab035 $2 doi
- 035 __
- $a (PubMed)33585931
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Mjøen, Geir $u Section of Nephrology, Department of Transplant Medicine, Oslo University Hospital, Oslo, Norway
- 245 10
- $a Long-term risks after kidney donation: how do we inform potential donors? A survey from DESCARTES and EKITA transplantation working groups / $c G. Mjøen, U. Maggiore, N. Kessaris, D. Kimenai, B. Watschinger, C. Mariat, MS. Sever, M. Crespo, L. Peruzzi, G. Spasovski, SS. Sørensen, U. Heemann, J. Pascual, O. Viklicky, AE. Courtney, K. Hadaya, L. Wagner, I. Nistor, V. Hadjianastassiou, M. Durlik, I. Helanterä, R. Oberbauer, G. Oniscu, L. Hilbrands, D. Abramowicz
- 520 9_
- $a BACKGROUND: Publications from the last decade have increased knowledge regarding long-term risks after kidney donation. We wanted to perform a survey to assess how transplant professionals in Europe inform potential kidney donors regarding long-term risks. The objectives of the survey were to determine how they inform donors and to what extent, and to evaluate the degree of variation. METHODS: All transplant professionals involved in the evaluation process were considered eligible, regardless of the type of profession. The survey was dispatched as a link to a web-based survey. The subjects included questions on demographics, the information policy of the respondent and the use of risk calculators, including the difference of relative and absolute risks and how the respondents themselves understood these risks. RESULTS: The main finding was a large variation in how often different long-term risks were discussed with the potential donors, i.e. from always to never. Eighty percent of respondents stated that they always discuss the risk of end-stage renal disease, while 56% of respondents stated that they always discuss the risk of preeclampsia. Twenty percent of respondents answered correctly regarding the relationship between absolute and relative risks for rare outcomes. CONCLUSIONS: The use of written information and checklists should be encouraged. This may improve standardization regarding the information provided to potential living kidney donors in Europe. There is a need for information and education among European transplant professionals regarding long-term risks after kidney donation and how to interpret and present these risks.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ledviny $7 D007668
- 650 12
- $a transplantace ledvin $x škodlivé účinky $7 D016030
- 650 _2
- $a žijící dárci $7 D019520
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 650 _2
- $a odběr tkání a orgánů $7 D020858
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Maggiore, Umberto $u Department of Medicine and Surgery, University of Parma, Parma, Italy
- 700 1_
- $a Kessaris, Nicos $u Guy's and St Thomas' Hospitals, London, UK
- 700 1_
- $a Kimenai, Diederik $u Erasmus University Hospital Rotterdam, Rotterdam, The Netherlands
- 700 1_
- $a Watschinger, Bruno $u Medical University of Vienna, Department of Medicine III, Division of Nephrology and Dialysis, Vienna, Austria
- 700 1_
- $a Mariat, Cristophe $u Centre Hospitalier Universitaire de Saint Etienne, Saint Etienne, France
- 700 1_
- $a Sever, Mehmet Sukru $u Istanbul School of Medicine, Istanbul, Turkey
- 700 1_
- $a Crespo, Marta $u Hospital del Mar, Department of Nephrology, Barcelona, Spain
- 700 1_
- $a Peruzzi, Licia $u Pediatric Nephrology, Turin, Italy
- 700 1_
- $a Spasovski, Goce $u University Clinic of Nephrology, Skopje, North Macedonia
- 700 1_
- $a Sørensen, Søren Schwartz $u Rigshospitalet, København, Denmark
- 700 1_
- $a Heemann, Uwe $u Technische Universität München, München, Germany
- 700 1_
- $a Pascual, Julio $u Hospital del Mar, Department of Nephrology, Barcelona, Spain
- 700 1_
- $a Viklicky, Ondrej $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Courtney, Aisling E $u Belfast City Hospital, Belfast, UK
- 700 1_
- $a Hadaya, Karine $u Geneva University Hospitals, Geneva, Switzerland
- 700 1_
- $a Wagner, Laszlo $u Semmelweiss University, Budapest, Hungary
- 700 1_
- $a Nistor, Ionut $u Methodological Center for Medical Research and Evidence-Based Medicine, University of Medicine and Pharmacy "Grigore T. Popa", Iasi, Romania
- 700 1_
- $a Hadjianastassiou, Vassilis $u Renal Unit, Royal London Hospital, Whitechapel, Bart's Health, NHS Trust, London, UK $u University of Nicosia, Nicosia, Cyprus
- 700 1_
- $a Durlik, Magdalena $u Medical University of Warsaw, Warsaw, Poland
- 700 1_
- $a Helanterä, Ilkka $u Helsinki University Hospital, Helsinki, Finland
- 700 1_
- $a Oberbauer, Rainer $u Medical University of Vienna, Department of Medicine III, Division of Nephrology and Dialysis, Vienna, Austria
- 700 1_
- $a Oniscu, Gabriel $u Royal Infirmary of Edinburgh, Edinburgh, UK
- 700 1_
- $a Hilbrands, Luuk $u Radboud University Medical Center, Nijmegen, The Netherlands
- 700 1_
- $a Abramowicz, Daniel $u Antwerp University Hospital, Antwerp, Belgium
- 773 0_
- $w MED00010288 $t Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association $x 1460-2385 $g Roč. 36, č. 9 (2021), s. 1742-1753
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33585931 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145740 $b ABA008
- 999 __
- $a ok $b bmc $g 1751375 $s 1155039
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 36 $c 9 $d 1742-1753 $e 20210827 $i 1460-2385 $m Nephrology, dialysis, transplantation $n Nephrol Dial Transplant $x MED00010288
- LZP __
- $a Pubmed-20220113